Daniel Putzer

[18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma

Markus Hutterer, Martha Nowosielski, Daniel Putzer et al. · Neuro-Oncology · 2013 · 241 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Bone Metastases in Patients with Neuroendocrine Tumor: ⁶⁸Ga-DOTA-Tyr³-Octreotide PET in Comparison to CT and Bone Scintigraphy

Daniel Putzer, Michael Gabriel, Benjamin Henninger et al. · Journal of Nuclear Medicine · 2009 · 218 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

⁶⁸Ga-DOTA-Tyr³-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy

Michael Gabriel, Andreas Oberauer, Georg Dobrozemsky et al. · Journal of Nuclear Medicine · 2009 · 189 citations · Full text

Medicine, Dermatology, Ophthalmology +14

<i>O</i>-(2-¹⁸F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma

Markus Hutterer, Martha Nowosielski, Daniel Putzer et al. · Journal of Nuclear Medicine · 2011 · 167 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation

Gregor Laimer, Peter Schullian, Nikolai Jaschke et al. · European Radiology · 2020 · 127 citations · Full text

Medicine, Oncology, Radiology +17